论文部分内容阅读
目的:研究普米克令舒对小儿毛细支气管炎的临床治疗效果。方法:选取120例我院2009.8-2013.8期间收治的毛细支气管炎患儿,将所有患者随机分为两组各60例,其中60例患儿使用常规抗病毒、抗感染等治疗作为对照组;另60例患儿在与对照组相同治疗的基础上外加普米克令舒雾化吸入治疗作为观察组。结果:治疗后结果发现,观察组患儿治疗总有效率以及不良反应发生率分别为90%、5%;对照组患儿治疗总有效率以及不良反应发生率分别为76.67%、15%,观察组患儿明显更好,P<0.05。结论:普米克令舒对于治疗小儿毛细支气管炎效果显著,不良反应小,值得临床应用及推广。
Objective: To study the clinical effect of pulmicort on children with bronchiolitis. Methods: A total of 120 children with bronchiolitis were enrolled from 2009.8 to 2013.8 in our hospital. All patients were randomly divided into two groups of 60 cases, of which 60 cases were treated with routine anti-virus and anti-infection as control group. 60 cases of children with the same treatment as the control group plus Pulmicort respiration inhalation therapy as the observation group. Results: After treatment, the total effective rate of treatment and adverse reactions in the observation group were 90% and 5% respectively. The total effective rate and incidence of adverse reactions in the control group were 76.67% and 15%, respectively. Group children were significantly better, P <0.05. Conclusion: Pulmicort respirator is effective in treating children with bronchiolitis, and its adverse reactions are small. It is worthy of clinical application and promotion.